Armata Pharmaceuticals
ARMP

Armata Pharmaceuticals (ARMP) analyst forecast and price target

Analyst forecast

Buy

Consensus of 2 analyst ratings

Buy
2
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$15.00 from $9.00Feb 23, 2026
Jones TradingInitiated CoverageBuy$15.00Jan 5, 2026
HC Wainwright & Co.MaintainedBuy$9.00 from $7.00May 19, 2025
HC Wainwright & Co.MaintainedBuy$7.00Dec 19, 2024
HC Wainwright & Co.MaintainedBuy$7.00Nov 14, 2024
HC Wainwright & Co.MaintainedBuy$7.00Nov 12, 2024
HC Wainwright & Co.MaintainedBuy$7.00Aug 15, 2024
HC Wainwright & Co.MaintainedBuy$7.00Jul 11, 2024
HC Wainwright & Co.MaintainedBuy$7.00May 8, 2024
HC Wainwright & Co.MaintainedBuy$7.00Mar 22, 2024
HC Wainwright & Co.MaintainedBuy$7.00Aug 14, 2023
HC Wainwright & Co.MaintainedBuy$7.00May 12, 2023
HC Wainwright & Co.MaintainedBuy$7.00Mar 17, 2023
HC Wainwright & Co.MaintainedBuy$7.00Mar 7, 2023

Frequently asked questions

  • Is ARMP a buy, sell, or hold?

    Analysts covering Armata Pharmaceuticals currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on ARMP?

    On Feb 23, 2026, HC Wainwright & Co. maintained Armata Pharmaceuticals at Buy with a price target of $15.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.